OptimizeRx Corp. (OPRX) Stock Rating Upgraded by ValuEngine
OptimizeRx Corp. (OTCMKTS:OPRX) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday.
Shares of OptimizeRx Corp. (OPRX) traded down 0.0079% on Friday, hitting $1.2699. The stock had a trading volume of 2,805 shares. OptimizeRx Corp. has a one year low of $0.63 and a one year high of $1.30. The firm’s 50 day moving average is $1.17 and its 200-day moving average is $0.89. The stock’s market capitalization is $37.15 million.
OptimizeRx Corp. (OTCMKTS:OPRX) last released its earnings results on Tuesday, August 1st. The technology company reported ($0.01) earnings per share (EPS) for the quarter. OptimizeRx Corp. had a negative return on equity of 25.08% and a negative net margin of 20.24%. The company had revenue of $2.87 million for the quarter. Equities research analysts expect that OptimizeRx Corp. will post ($0.06) earnings per share for the current fiscal year.
About OptimizeRx Corp.
OptimizeRx Corporation is a technology solutions company. The Company focuses on the healthcare industry. The Company connects patients, physicians and pharmaceutical manufacturers through technology. The Company’s solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting products.
Receive News & Stock Ratings for OptimizeRx Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx Corp. and related stocks with our FREE daily email newsletter.